Related Experiment Video
Updated: Jul 13, 2026
12:24
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
Defining optimal therapeutic outcomes in chronic hepatitis
Mauricio Lisker-Melman1, Gregory S Sayuk
1Division of Gastroenterology, Hepatology Program, Washington University School of Medicine, St. Louis, Missouri 63110-1010, USA. mlisker@im.wustl.edu
Archives of Medical Research
|July 7, 2007
Summary
As diagnostic tests advance, therapeutic success criteria for chronic viral hepatitis B and C become more stringent. Viral suppression is a current goal for hepatitis B, while hepatitis C aims for sustained virologic response.
Area of Science:
- Hepatology
- Virology
- Clinical Diagnostics
Background:
- The definition of optimal therapeutic response in viral hepatitis is evolving with advancements in diagnostic technologies.
- Increased sensitivity of laboratory tools necessitates more stringent criteria for successful treatment outcomes.
- Current treatment objectives focus on viral eradication, hepatic injury reduction, and disease progression prevention.
Purpose of the Study:
- To discuss the evolving definitions of therapeutic response in chronic viral hepatitis B and C.
- To highlight the impact of improved diagnostic sensitivity on treatment goals.
- To explore the future therapeutic landscape for chronic viral hepatitis.
Main Methods:
- Review of current literature on diagnostic advancements in viral hepatitis.
- Analysis of evolving treatment objectives for hepatitis B and C.
- Discussion of the implications of enhanced test sensitivity on therapeutic outcomes.
Main Results:
- Therapeutic success is now defined more stringently due to more sensitive diagnostic tests.
- Viral suppression is a realistic objective for hepatitis B, with eradication as the ultimate goal.
- Sustained virologic response (absence of HCV RNA post-treatment) is achievable for hepatitis C.
Conclusions:
- Enhanced diagnostic sensitivity provides greater confidence in achieving viral eradication, particularly for hepatitis C.
- Despite progress, challenges remain in the treatment of chronic viral hepatitis.
- Development of more efficacious and better-tolerated drugs is anticipated to reshape treatment paradigms.
Related Concept Videos
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:11Guidelines for Writing Outcome
When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care evaluation by...
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care evaluation by...
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:14Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...